These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2103497)

  • 1. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies.
    Goldenberg DM; Blumenthal RD; Sharkey RM
    Semin Cancer Biol; 1990 Jun; 1(3):217-25. PubMed ID: 2103497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
    Goldenberg DM
    Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy.
    Goldenberg DM
    Arch Pathol Lab Med; 1988 Jun; 112(6):580-7. PubMed ID: 3288167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
    Larson SM
    Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
    Britton KE
    Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of radiolabeled monoclonal antibodies for diagnostic imaging].
    Endo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):901-9. PubMed ID: 2235337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New radiopharmaceuticals for oncologic diagnosis and therapy: developments in radioimmunoscintigraphy and radioimmunotherapy].
    Eisenhut M; Brandau W; Reinel U; Kimmig B
    Rontgenblatter; 1989 Jan; 42(1):24-7. PubMed ID: 2645635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings.
    Behr TM; Béhé M; Sgouros G
    Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanoma.
    Divgi CR; Larson SM
    Semin Nucl Med; 1989 Oct; 19(4):252-61. PubMed ID: 2678478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent achievements in the development of radiolabeled monoclonal antibodies for diagnosis, therapy and biologic characterization of human tumors.
    Larson SM; Macapinlac HA; Scott AM; Divgi CR
    Acta Oncol; 1993; 32(7-8):709-15. PubMed ID: 8305216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies.
    Goldenberg DM
    Am J Gastroenterol; 1991 Oct; 86(10):1392-403. PubMed ID: 1656726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.
    Carrasquillo JA; Krohn KA; Beaumier P; McGuffin RW; Brown JP; Hellström KE; Hellström I; Larson SM
    Cancer Treat Rep; 1984 Jan; 68(1):317-28. PubMed ID: 6607111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.
    Breitz HB; Weiden PL; Vanderheyden JL; Appelbaum JW; Bjorn MJ; Fer MF; Wolf SB; Ratliff BA; Seiler CA; Foisie DC
    J Nucl Med; 1992 Jun; 33(6):1099-109. PubMed ID: 1597723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.
    Larson SM
    J Nucl Med; 1985 May; 26(5):538-45. PubMed ID: 3989608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled antibodies as in-vivo cancer probes (review).
    Goldenberg D; Sharkey R
    Int J Oncol; 1993 Jul; 3(1):5-11. PubMed ID: 21573317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.